Related Experiment Videos
Progesterone modulates a neuronal nicotinic acetylcholine receptor.
S Valera1, M Ballivet, D Bertrand
1Department of Biochemistry, Sciences II, Centre Medical Universitaire, Geneva, Switzerland.
Summary
Progesterone inhibits brain nicotinic acetylcholine receptors (nAChRs) by binding to the extracellular domain. This interaction, distinct from open channel blocking, affects receptor function without altering membrane properties or second messengers.
Area of Science:
- Neuroscience
- Molecular Pharmacology
- Receptor Biology
Background:
- Nicotinic acetylcholine receptors (nAChRs) are crucial for brain function.
- The alpha 4 and n alpha 1 subunits form a major brain nAChR subtype.
- Serum progesterone levels can inhibit these receptors.
Purpose of the Study:
- To elucidate the mechanism by which progesterone inhibits alpha 4/n alpha 1 nAChRs.
- To determine the specific binding site and mode of action of progesterone.
Main Methods:
- Expression of alpha 4/n alpha 1 nAChRs in Xenopus oocytes.
- Electrophysiological recordings to assess receptor function and inhibition.
- Investigated effects of progesterone under various conditions (agonist presence, voltage, ionic permeability).
Main Results:
- Progesterone binds to the extracellular domain of the nAChR.
- Inhibition is not due to membrane perturbation or second messenger activation.
- Progesterone is not an open channel blocker and its action is voltage-independent.
- Progesterone may interact with the acetylcholine binding site but is not a competitive inhibitor.
Conclusions:
- Progesterone inhibits alpha 4/n alpha 1 nAChRs via a non-competitive mechanism at the extracellular domain.
- The steroid's interaction is independent of receptor desensitization and ionic permeability.
- Findings clarify the molecular basis of neurosteroid modulation of nAChRs.